Cargando…
High-throughput drug screening reveals Pyrvinium pamoate as effective candidate against pediatric MLL-rearranged acute myeloid leukemia
Pediatric MLL-rearranged acute myeloid leukemia (AML) has a generally unfavorable outcome, primarily due to relapse and drug resistance. To overcome these difficulties, new therapeutic agents are urgently needed. Yet, implementing novel drugs for clinical use is a time-consuming, laborious, costly a...
Autores principales: | Wander, Priscilla, Arentsen-Peters, Susan T.C.J.M., Pinhanҫos, Sandra S., Koopmans, Bianca, Dolman, M.Emmy M., Ariese, Rijndert, Bos, Frank L., Castro, Patricia Garrido, Jones, Luke, Schneider, Pauline, Navarro, Miriam Guillen, Molenaar, Jan J., Rios, Anne C., Zwaan, C. Michel, Stam, Ronald W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933809/ https://www.ncbi.nlm.nih.gov/pubmed/33667892 http://dx.doi.org/10.1016/j.tranon.2021.101048 |
Ejemplares similares
-
High-Throughput Drug Library Screening in Primary KMT2A-Rearranged Infant ALL Cells Favors the Identification of Drug Candidates That Activate P53 Signaling
por: Wander, Priscilla, et al.
Publicado: (2022) -
Pyrvinium Pamoate and Structural Analogs Are Early Macrofilaricide Leads
por: Gunderson, Emma L., et al.
Publicado: (2022) -
The Antihelmintic Drug Pyrvinium Pamoate Targets Aggressive Breast Cancer
por: Xu, Wei, et al.
Publicado: (2013) -
Pyrvinium Pamoate: Past, Present, and Future as an Anti-Cancer Drug
por: Schultz, Christopher W., et al.
Publicado: (2022) -
Pyrvinium pamoate can overcome artemisinin’s resistance in anaplastic thyroid cancer
por: Li, Yitian
Publicado: (2021)